INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 103 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $737,000 | +27.5% | 43,625 | 0.0% | 0.50% | +31.7% |
| Q3 2014 | $578,000 | +1.0% | 43,625 | -2.9% | 0.38% | +10.4% |
| Q2 2014 | $572,000 | +31.8% | 44,925 | -3.0% | 0.35% | +14.2% |
| Q1 2014 | $434,000 | -21.4% | 46,325 | +2.0% | 0.30% | -18.5% |
| Q4 2013 | $552,000 | -56.8% | 45,425 | -39.1% | 0.37% | -66.3% |
| Q3 2013 | $1,278,000 | – | 74,575 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |